Review
doi: 10.14670/HH-22.905.
Advances of MUC1 as a target for breast cancer immunotherapy
Affiliations
- PMID: 17503348
- DOI: 10.14670/HH-22.905
Item in Clipboard
Review
Advances of MUC1 as a target for breast cancer immunotherapy
Histol Histopathol.
2007 Aug.
Abstract
MUC1 is a potential target in breast cancer immunotherapy as MUC1 is overexpressed in breast cancer, and is absent or expressed in low level in normal mammary gland. In addition, MUC1 is mostly aberrantly underglycosylated in cancer and the antigens on the cancer surface are different from normal cell. Therefore targeting MUC1 for cancer immunotherapy can exploit the difference between cancer and normal cells, and eliminating the cancerous cells while leaving the normal mammary cells unharmed. This review will focus on the recent advance of MUC1 breast cancer immunotherapy currently being investigated.
Similar articles
-
MUC1 immunotherapy.Immunotherapy. 2010 May;2(3):305-27. doi: 10.2217/imt.10.17. Immunotherapy. 2010. PMID: 20635898 Review.
-
MUC1: a target molecule for cancer therapy.Cancer Biol Ther. 2007 Apr;6(4):481-6. doi: 10.4161/cbt.6.4.4201. Cancer Biol Ther. 2007. PMID: 18027437 Review.
-
Tecemotide: an antigen-specific cancer immunotherapy.Hum Vaccin Immunother. 2014;10(11):3383-93. doi: 10.4161/hv.29836. Hum Vaccin Immunother. 2014. PMID: 25483673 Free PMC article. Review.
-
Dendritic cell vaccine immunotherapy of cancer targeting MUC1 mucin.Int J Mol Med. 2003 Oct;12(4):493-502. Int J Mol Med. 2003. PMID: 12964025
-
MUC1 and breast cancer.Curr Opin Mol Ther. 1999 Feb;1(1):98-103. Curr Opin Mol Ther. 1999. PMID: 11249691 Review.
Cited by
-
Establishment and characterization of two primary breast cancer cell lines from young Indian breast cancer patients: mutation analysis.Cancer Cell Int. 2014 Feb 5;14(1):14. doi: 10.1186/1475-2867-14-14. Cancer Cell Int. 2014. PMID: 24502646 Free PMC article.
-
Clinical and prognostic significance of signal transducer and activator of transcription 3 and mucin 1 in patients with non-small cell lung cancer following surgery.Oncol Lett. 2018 Apr;15(4):4278-4288. doi: 10.3892/ol.2018.7858. Epub 2018 Jan 25. Oncol Lett. 2018. PMID: 29541195 Free PMC article.
-
Exploring the structural constraints at cleavage site of mucin 1 isoform through molecular dynamics simulation.Eur Biophys J. 2015 Jul;44(5):309-23. doi: 10.1007/s00249-015-1023-z. Epub 2015 Apr 11. Eur Biophys J. 2015. PMID: 25861899
-
Comprehensive integrated analysis of gene expression datasets identifies key anti-cancer targets in different stages of breast cancer.Exp Ther Med. 2018 Aug;16(2):802-810. doi: 10.3892/etm.2018.6268. Epub 2018 Jun 7. Exp Ther Med. 2018. PMID: 30112036 Free PMC article.
-
Detection of circulating anti-mucin 1 (MUC1) antibodies in breast tumor patients by indirect enzyme-linked immunosorbent assay using a recombinant MUC1 protein containing six tandem repeats and expressed in Escherichia coli.Clin Vaccine Immunol. 2010 Dec;17(12):1903-8. doi: 10.1128/CVI.00142-10. Epub 2010 Sep 28. Clin Vaccine Immunol. 2010. PMID: 20876819 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
